JP2010537157A5 - - Google Patents

Download PDF

Info

Publication number
JP2010537157A5
JP2010537157A5 JP2010517019A JP2010517019A JP2010537157A5 JP 2010537157 A5 JP2010537157 A5 JP 2010537157A5 JP 2010517019 A JP2010517019 A JP 2010517019A JP 2010517019 A JP2010517019 A JP 2010517019A JP 2010537157 A5 JP2010537157 A5 JP 2010537157A5
Authority
JP
Japan
Prior art keywords
biomarkers
subject
level
diabetes
biological sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010517019A
Other languages
English (en)
Japanese (ja)
Other versions
JP5701601B2 (ja
JP2010537157A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/008756 external-priority patent/WO2009014639A2/en
Publication of JP2010537157A publication Critical patent/JP2010537157A/ja
Publication of JP2010537157A5 publication Critical patent/JP2010537157A5/ja
Application granted granted Critical
Publication of JP5701601B2 publication Critical patent/JP5701601B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010517019A 2007-07-17 2008-07-17 糖尿病前症、心血管疾患及びその他のメタボリックシンドローム関連障害のバイオマーカー並びにその使用方法 Active JP5701601B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US95028607P 2007-07-17 2007-07-17
US60/950,286 2007-07-17
US3762808P 2008-03-18 2008-03-18
US61/037,628 2008-03-18
PCT/US2008/008756 WO2009014639A2 (en) 2007-07-17 2008-07-17 Biomarkers for pre-diabetes, cardiovascular diseases, and other metabolic-syndrome related disorders and methods using the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014218116A Division JP5876918B2 (ja) 2007-07-17 2014-10-27 糖尿病前症、心血管疾患及びその他のメタボリックシンドローム関連障害のバイオマーカー並びにその使用方法

Publications (3)

Publication Number Publication Date
JP2010537157A JP2010537157A (ja) 2010-12-02
JP2010537157A5 true JP2010537157A5 (https=) 2011-10-27
JP5701601B2 JP5701601B2 (ja) 2015-04-15

Family

ID=40282019

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2010517019A Active JP5701601B2 (ja) 2007-07-17 2008-07-17 糖尿病前症、心血管疾患及びその他のメタボリックシンドローム関連障害のバイオマーカー並びにその使用方法
JP2014218116A Active JP5876918B2 (ja) 2007-07-17 2014-10-27 糖尿病前症、心血管疾患及びその他のメタボリックシンドローム関連障害のバイオマーカー並びにその使用方法
JP2015236454A Pending JP2016102797A (ja) 2007-07-17 2015-12-03 糖尿病前症、心血管疾患及びその他のメタボリックシンドローム関連障害のバイオマーカー並びにその使用方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2014218116A Active JP5876918B2 (ja) 2007-07-17 2014-10-27 糖尿病前症、心血管疾患及びその他のメタボリックシンドローム関連障害のバイオマーカー並びにその使用方法
JP2015236454A Pending JP2016102797A (ja) 2007-07-17 2015-12-03 糖尿病前症、心血管疾患及びその他のメタボリックシンドローム関連障害のバイオマーカー並びにその使用方法

Country Status (9)

Country Link
US (5) US8187830B2 (https=)
EP (1) EP2164977B1 (https=)
JP (3) JP5701601B2 (https=)
AU (1) AU2008279778B2 (https=)
BR (1) BRPI0815095B1 (https=)
CA (1) CA2690541A1 (https=)
ES (1) ES2443540T3 (https=)
MX (3) MX2010000414A (https=)
WO (1) WO2009014639A2 (https=)

Families Citing this family (129)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2339346B1 (en) * 2006-03-24 2014-09-03 Metanomics GmbH Methods for predicting diabetes type II
WO2008015929A1 (fr) * 2006-08-04 2008-02-07 Ajinomoto Co., Inc. procédé d'évaluation de syndrome métabolique, appareil D'ÉVALUATION DE SYNDROME MÉTABOLIQUE, système D'ÉVALUATION DE SYNDROME MÉTABOLIQUE, programme d'évaluation de syndrome métabolique et support d'enregistrement, et proc&
US9867530B2 (en) 2006-08-14 2018-01-16 Volcano Corporation Telescopic side port catheter device with imaging system and method for accessing side branch occlusions
JPWO2009001862A1 (ja) * 2007-06-25 2010-08-26 味の素株式会社 内臓脂肪蓄積の評価方法
US9596993B2 (en) 2007-07-12 2017-03-21 Volcano Corporation Automatic calibration systems and methods of use
US9622706B2 (en) 2007-07-12 2017-04-18 Volcano Corporation Catheter for in vivo imaging
US10219780B2 (en) 2007-07-12 2019-03-05 Volcano Corporation OCT-IVUS catheter for concurrent luminal imaging
MX2010000414A (es) 2007-07-17 2010-04-01 Metabolon Inc Biomarcadores para prediabetes, enfermedades cardiovasculares y otros trastornos relacionados con sindrome metabolico, y metodos de uso de los mismos.
EP2209001A4 (en) * 2007-10-25 2010-10-27 Ajinomoto Kk METHOD FOR ASSESSING STROKEN GLUCOSE TOLERANCE
JP5270684B2 (ja) * 2007-11-02 2013-08-21 メタボロン、インコーポレイテッド 脂肪肝疾患用のバイオマーカー及びその使用方法
DK2240781T3 (en) 2008-01-18 2018-03-26 Harvard College METHODS FOR DETECTING DISEASE OR STATE SIGNATURES IN BODY FLUIDS
JP5415520B2 (ja) * 2008-04-09 2014-02-12 ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング 最大酸素消費量低下の予測のためのプロ−エンドセリン−1
US20100222315A1 (en) * 2008-09-24 2010-09-02 Harbor BioSciencs, Inc. Patient populations and treatment methods
KR20110086074A (ko) * 2008-10-20 2011-07-27 리포사이언스, 인크. 지질단백질 인슐린 저항성 지표 및 이와 관련된 방법, 시스템 및 이를 생성하기 위한 컴퓨터 프로그램
CA2755050A1 (en) 2009-03-10 2010-09-16 Duke University Predicting coronary artery disease and risk of cardiovascular events
US20120122981A1 (en) * 2009-03-31 2012-05-17 Yun Fu Hu Biomarkers Related to Insulin Resistance and Methods using the Same
AU2010247800A1 (en) 2009-05-11 2011-12-15 Berg Llc Methods for the diagnosis of metabolic disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
WO2011031803A1 (en) * 2009-09-08 2011-03-17 Nodality, Inc. Analysis of cell networks
JP5787339B2 (ja) * 2009-12-28 2015-09-30 学校法人福岡大学 糖尿病前症の検査方法
EP2550533A4 (en) * 2010-03-23 2014-01-08 Purdue Research Foundation EARLY RECOGNITION OF RECYCLING BREAST CANCER BY METABOLIT PROFILING
KR101873193B1 (ko) 2010-06-08 2018-07-02 아사히 그룹 홀딩스 가부시키가이샤 지질 대사 개선제
EP2596134B1 (en) 2010-07-23 2020-04-08 President and Fellows of Harvard College Methods of detecting diseases or conditions using phagocytic cells
WO2012012693A2 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
CA2806304A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
EP2596349B1 (en) 2010-07-23 2017-12-13 President and Fellows of Harvard College Methods of detecting cardiovascular diseases or conditions
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
WO2012013667A1 (en) * 2010-07-30 2012-02-02 Technische Universität Graz Analyses of analytes by mass spectrometry with values in at least 3 dimensions
WO2012058298A1 (en) * 2010-10-26 2012-05-03 Mayo Foundation For Medical Education And Research Biomarkers of reduced insulin action
US11141063B2 (en) 2010-12-23 2021-10-12 Philips Image Guided Therapy Corporation Integrated system architectures and methods of use
BR112013016071A2 (pt) * 2010-12-23 2016-09-20 Metanomics Health Gmbh "métodos, dispositivo e kit de diagnóstico de diabete e uso de glioxilato ou um agente de detecção para glioxilato"
US11040140B2 (en) 2010-12-31 2021-06-22 Philips Image Guided Therapy Corporation Deep vein thrombosis therapeutic methods
WO2012116074A1 (en) * 2011-02-22 2012-08-30 Mayo Foundation For Medical Education And Research Biomarkers of insulin sensitivity
CA2832324C (en) 2011-04-04 2022-03-15 Berg Llc Methods of treating central nervous system tumors
WO2013002381A1 (ja) 2011-06-30 2013-01-03 味の素株式会社 脂肪性肝疾患の評価方法、脂肪性肝疾患評価装置、脂肪性肝疾患評価方法、脂肪性肝疾患評価プログラム、脂肪性肝疾患評価システム、情報通信端末装置、および脂肪性肝疾患の予防・改善物質の探索方法
CA2841915A1 (en) * 2011-07-28 2013-01-31 Metanomics Gmbh Means and methods for diagnosing and monitoring heart failure in a subject
WO2013033592A1 (en) 2011-08-31 2013-03-07 Volcano Corporation Optical-electrical rotary joint and methods of use
US10302663B2 (en) 2011-09-14 2019-05-28 Metabolon, Inc. Method of assessing pancreatic beta-cell function
WO2013122469A2 (en) * 2012-02-17 2013-08-22 Rijksuniversiteit Groningen Prediction of the efficacy of a medicament on renal or cardiovascular clinical outcomes
EP2642297A1 (en) * 2012-03-22 2013-09-25 Nestec S.A. Hydroxy-sphingomyelin 22:1 as biomarker for healthy ageing
EP2642293A1 (en) * 2012-03-22 2013-09-25 Nestec S.A. 9-oxo-octadecadienoic acid (9-oxo-HODE)as as biomarker for healthy ageing
EP2642294A1 (en) * 2012-03-22 2013-09-25 Nestec S.A. Phenylacetylglutamine as biomarker for healthy ageing
EP2642296A1 (en) * 2012-03-22 2013-09-25 Nestec S.A. p-Cresol sulphate as biomarker for healthy ageing
EP2642295A1 (en) 2012-03-22 2013-09-25 Nestec S.A. 1-O-alkyl-2-acylglycerophosphocholine (PC-O) 40:1 as biomarker for healthy ageing
CN104364658B (zh) * 2012-06-05 2017-06-30 雀巢产品技术援助有限公司 用于诊断慢性瓣膜疾病的方法
US9928345B2 (en) 2012-06-08 2018-03-27 Liposciences, Inc. Multiple-marker risk parameters predictive of conversion to diabetes
US9361429B2 (en) 2012-06-08 2016-06-07 Liposcience, Inc. Multi-parameter diabetes risk evaluations
WO2013188846A1 (en) 2012-06-15 2013-12-19 Harry Stylli Methods of detecting diseases or conditions
EP2861788B1 (en) 2012-06-15 2018-10-10 Progenity, Inc. Methods of detecting diseases or conditions using circulating diseased cells
JP6282642B2 (ja) 2012-06-27 2018-02-21 メタノミクス ヘルス ゲーエムベーハー 糖尿病薬を同定する方法
US9546994B2 (en) * 2012-08-13 2017-01-17 Helmholtz Zentrum Munchen-Deutsches Forschungszentrum fur Geseundheit und Umwelt (GmbH) Biomarkers for type 2 diabetes
US20140324460A1 (en) * 2012-09-26 2014-10-30 Health Diagnostic Laboratory, Inc. Method for determining and managing total cardiodiabetes risk
US9858668B2 (en) 2012-10-05 2018-01-02 Volcano Corporation Guidewire artifact removal in images
US11272845B2 (en) 2012-10-05 2022-03-15 Philips Image Guided Therapy Corporation System and method for instant and automatic border detection
US10070827B2 (en) 2012-10-05 2018-09-11 Volcano Corporation Automatic image playback
US9307926B2 (en) 2012-10-05 2016-04-12 Volcano Corporation Automatic stent detection
WO2014055880A2 (en) 2012-10-05 2014-04-10 David Welford Systems and methods for amplifying light
US9324141B2 (en) 2012-10-05 2016-04-26 Volcano Corporation Removal of A-scan streaking artifact
US20140100454A1 (en) 2012-10-05 2014-04-10 Volcano Corporation Methods and systems for establishing parameters for three-dimensional imaging
US9292918B2 (en) 2012-10-05 2016-03-22 Volcano Corporation Methods and systems for transforming luminal images
US10568586B2 (en) 2012-10-05 2020-02-25 Volcano Corporation Systems for indicating parameters in an imaging data set and methods of use
US9286673B2 (en) 2012-10-05 2016-03-15 Volcano Corporation Systems for correcting distortions in a medical image and methods of use thereof
US9367965B2 (en) 2012-10-05 2016-06-14 Volcano Corporation Systems and methods for generating images of tissue
US9840734B2 (en) 2012-10-22 2017-12-12 Raindance Technologies, Inc. Methods for analyzing DNA
WO2014093374A1 (en) 2012-12-13 2014-06-19 Volcano Corporation Devices, systems, and methods for targeted cannulation
US9709379B2 (en) 2012-12-20 2017-07-18 Volcano Corporation Optical coherence tomography system that is reconfigurable between different imaging modes
US11406498B2 (en) 2012-12-20 2022-08-09 Philips Image Guided Therapy Corporation Implant delivery system and implants
US10942022B2 (en) 2012-12-20 2021-03-09 Philips Image Guided Therapy Corporation Manual calibration of imaging system
US10939826B2 (en) 2012-12-20 2021-03-09 Philips Image Guided Therapy Corporation Aspirating and removing biological material
US10595820B2 (en) 2012-12-20 2020-03-24 Philips Image Guided Therapy Corporation Smooth transition catheters
WO2014113188A2 (en) 2012-12-20 2014-07-24 Jeremy Stigall Locating intravascular images
US9486143B2 (en) 2012-12-21 2016-11-08 Volcano Corporation Intravascular forward imaging device
WO2014099760A1 (en) 2012-12-21 2014-06-26 Mai Jerome Ultrasound imaging with variable line density
WO2014099672A1 (en) 2012-12-21 2014-06-26 Andrew Hancock System and method for multipath processing of image signals
US10058284B2 (en) 2012-12-21 2018-08-28 Volcano Corporation Simultaneous imaging, monitoring, and therapy
JP2016508233A (ja) 2012-12-21 2016-03-17 ナサニエル ジェイ. ケンプ, 光学スイッチを用いた電力効率のよい光学バッファリング
WO2014100530A1 (en) 2012-12-21 2014-06-26 Whiseant Chester System and method for catheter steering and operation
CA2896006A1 (en) 2012-12-21 2014-06-26 David Welford Systems and methods for narrowing a wavelength emission of light
US9612105B2 (en) 2012-12-21 2017-04-04 Volcano Corporation Polarization sensitive optical coherence tomography system
JP2016508757A (ja) 2012-12-21 2016-03-24 ジェイソン スペンサー, 医療データのグラフィカル処理のためのシステムおよび方法
JP2016502884A (ja) 2012-12-21 2016-02-01 ダグラス メイヤー, 延在カテーテル本体テレスコープを有する回転可能超音波撮像カテーテル
WO2014118634A1 (en) 2013-01-31 2014-08-07 Eustache Paramithiotis Type 2 diabetes biomarkers and uses thereof
WO2014120449A1 (en) * 2013-01-31 2014-08-07 Metabolon, Inc. Biomarkers related to insulin resistance progression and methods using the same
DE112014000822T5 (de) * 2013-02-14 2015-10-29 Metanomics Health Gmbh Mittel und Verfahren zur Beurteilung der Qualität einer biologischen Probe
US10226597B2 (en) 2013-03-07 2019-03-12 Volcano Corporation Guidewire with centering mechanism
WO2014138555A1 (en) 2013-03-07 2014-09-12 Bernhard Sturm Multimodal segmentation in intravascular images
US11585814B2 (en) 2013-03-09 2023-02-21 Immunis.Ai, Inc. Methods of detecting prostate cancer
EP2965077B1 (en) 2013-03-09 2022-07-13 Harry Stylli Methods of detecting cancer
US20140276923A1 (en) 2013-03-12 2014-09-18 Volcano Corporation Vibrating catheter and methods of use
CN105228518B (zh) 2013-03-12 2018-10-09 火山公司 用于诊断冠状微脉管疾病的系统和方法
US9301687B2 (en) 2013-03-13 2016-04-05 Volcano Corporation System and method for OCT depth calibration
US20140278121A1 (en) * 2013-03-13 2014-09-18 Robust for Life, Inc. Systems and methods for network-based calculation and reporting of metabolic risk
JP6339170B2 (ja) 2013-03-13 2018-06-06 ジンヒョン パーク 回転式血管内超音波装置から画像を生成するためのシステム及び方法
US11026591B2 (en) 2013-03-13 2021-06-08 Philips Image Guided Therapy Corporation Intravascular pressure sensor calibration
US20160030151A1 (en) 2013-03-14 2016-02-04 Volcano Corporation Filters with echogenic characteristics
US10219887B2 (en) 2013-03-14 2019-03-05 Volcano Corporation Filters with echogenic characteristics
US12343198B2 (en) 2013-03-14 2025-07-01 Philips Image Guided Therapy Corporation Delivery catheter having imaging capabilities
US10292677B2 (en) 2013-03-14 2019-05-21 Volcano Corporation Endoluminal filter having enhanced echogenic properties
SG10201903112WA (en) 2013-04-08 2019-05-30 Berg Llc Treatment of cancer using coenzyme q10 combination therapies
CA2921530A1 (en) * 2013-07-18 2015-01-22 True Health Diagnostics, Llc Method of determination of risk of 2 hour blood glucose equal to or greater than 140 mg/dl
KR102370843B1 (ko) 2013-09-04 2022-03-04 버그 엘엘씨 코엔자임 q10의 연속주입에 의한 암치료 방법
GB2524230A (en) * 2014-02-14 2015-09-23 Asda Stores Ltd Transaction processing system and transaction processing method
MA40636A (fr) 2014-09-11 2015-09-11 Colleen Kelly Procédés pour détecter le cancer de la prostate
US20170316176A1 (en) * 2014-12-25 2017-11-02 Hitachi, Ltd. Device for analyzing insulin secretion ability, system for analyzing insulin secretion ability provided with same, and method for analyzing insulin secretion ability
CA2973116C (en) * 2015-01-09 2023-08-15 Global Genomics Group, LLC Blood based biomarkers for diagnosing atherosclerotic coronary artery disease
WO2016149220A1 (en) 2015-03-13 2016-09-22 Duke University Compositions and methods for metabolic profiling in subjects with heart failure with preserved ejection fraction
JP6051258B2 (ja) * 2015-04-15 2016-12-27 ライオン株式会社 脂質異常症への罹患しやすさを試験する方法
KR101795689B1 (ko) * 2015-04-30 2017-11-30 경희대학교 산학협력단 혈관 협착 질환 진단용 마커 및 이의 용도
WO2017087576A1 (en) 2015-11-16 2017-05-26 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10
WO2018094204A1 (en) * 2016-11-17 2018-05-24 Arivale, Inc. Determining relationships between risks for biological conditions and dynamic analytes
US11881311B1 (en) 2017-02-17 2024-01-23 BioAge Labs, Inc. Survival prediction using metabolomic profiles
JP2018141728A (ja) * 2017-02-28 2018-09-13 トヨタ自動車株式会社 生活習慣病の診断方法
CA3080932A1 (en) 2017-11-22 2019-05-31 Mayo Foundation For Medical Education And Research Methods and materials for assessing and treating obesity
US20200041496A1 (en) * 2018-08-01 2020-02-06 Joshua Health Care LLC Methods for Identifying and Treating Mammalian Subjects with Insulin Resistance
JP7189537B2 (ja) * 2019-06-27 2022-12-14 サンスター株式会社 血液試料の酸化hdl量の反映値を測定する工程を含む、測定方法
JP7665157B2 (ja) * 2019-07-08 2025-04-21 株式会社島津製作所 移植用肝臓の機能評価方法、移植用肝臓の機能評価プログラムおよび移植用肝臓の機能評価装置
US20240085432A1 (en) * 2019-10-11 2024-03-14 The Regents Of The University Of California Metabolic profile screening for gestational diabetes
US20230091848A1 (en) * 2020-02-05 2023-03-23 The Cleveland Clinic Foundation Disease detection and treatment based on phenylacetyl glutamine levels
CN113866284B (zh) * 2020-06-30 2023-09-05 上海脉示生物技术有限公司 一组用于心力衰竭诊断的肠道微生物代谢标志物及其应用
CN112684064B (zh) * 2020-12-08 2022-05-17 安徽农业大学 用于筛选抗应激胁迫肉羊的血清代谢标志物及其应用
US20240115566A1 (en) * 2020-12-16 2024-04-11 St. Jude Children's Research Hospital, Inc. Methods of treating disorders associated with castor
CN113325117B (zh) * 2021-06-25 2022-07-15 中国医学科学院北京协和医院 一组生物标记物在制备预测静脉内平滑肌瘤病进展的试剂盒中的应用
CN115023608B (zh) * 2021-11-30 2024-01-19 江苏品生医疗科技集团有限公司 预测受试者患有糖尿病的可能性的标记物及其应用
CA3250296A1 (en) * 2022-01-28 2023-08-03 GATC Health Corp BIOMARKERS FOR THE EARLY DETECTION OF DIABETES
CN114965733B (zh) * 2022-04-07 2023-12-01 中国人民解放军总医院第一医学中心 结直肠进展期腺瘤诊断代谢标志物组合及其应用
CN116035609A (zh) * 2023-02-02 2023-05-02 上海市东方医院(同济大学附属东方医院) 葡萄糖转运蛋白作为心肌葡萄糖代谢异常诊断标志物的用途
WO2025019706A1 (en) * 2023-07-19 2025-01-23 Ahara Corporation Systems and methods for generating a nutrition program
CN117347529B (zh) * 2023-11-22 2026-02-17 中国人民解放军军事科学院军事医学研究院 肠道菌群和代谢物的应用以及高原心脏病的预测系统
JP2025112741A (ja) * 2024-01-22 2025-08-01 富士フイルム株式会社 情報管理装置及び情報管理装置の作動方法並びに情報管理プログラム
CN119846232B (zh) * 2025-01-21 2025-10-03 宁夏农林科学院动物科学研究所(宁夏草畜工程技术研究中心) 一种早期诊断奶牛隐性乳房炎的生物标志物组合及其应用

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5367052A (en) * 1987-04-27 1994-11-22 Amylin Pharmaceuticals, Inc. Amylin peptides
WO1997031103A1 (en) * 1996-02-20 1997-08-28 Kyowa Hakko Kogyo Co., Ltd. Method for determining 1,5-anhydroglucitol
JP2938048B1 (ja) * 1998-06-30 1999-08-23 技術研究組合医療福祉機器研究所 代謝機能測定装置
US6140067A (en) * 1999-04-30 2000-10-31 Mitokor Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus
JP3975279B2 (ja) * 1999-11-01 2007-09-12 旭化成ファーマ株式会社 糖尿病予備群の検査方法
US7329489B2 (en) * 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
US20020009740A1 (en) * 2000-04-14 2002-01-24 Rima Kaddurah-Daouk Methods for drug discovery, disease treatment, and diagnosis using metabolomics
YU8803A (sh) * 2000-08-07 2006-01-16 Ranbaxy Signature L.L.C. Tečni oblik metformina
WO2002098355A2 (en) * 2001-06-01 2002-12-12 Clingenix, Inc. Methods and reagents for diagnosis and treatment of insulin resistance and related conditions
US7425545B2 (en) * 2001-07-25 2008-09-16 Isis Pharmaceuticals, Inc. Modulation of C-reactive protein expression
JP4100673B2 (ja) * 2001-12-07 2008-06-11 日本化薬株式会社 肝糖放出の検査方法
JP2003204800A (ja) * 2002-01-15 2003-07-22 Sumitomo Pharmaceut Co Ltd 糖代謝異常疾患マーカーおよびその利用
WO2003087768A2 (en) * 2002-04-12 2003-10-23 Mitokor Targets for therapeutic intervention identified in the mitochondrial proteome
WO2004005338A1 (en) * 2002-07-08 2004-01-15 Genova, Ltd. Secreted peptides
JP2005006645A (ja) * 2003-05-22 2005-01-13 Sumitomo Chemical Co Ltd インスリン応答性の評価方法
WO2005094200A2 (en) * 2003-06-20 2005-10-13 University Of Florida Biomarkers for differentiating between type 2 and type 2 diabetes
US7345142B2 (en) * 2004-01-27 2008-03-18 Compugen Ltd. Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease
JP4547173B2 (ja) * 2004-03-17 2010-09-22 シスメックス株式会社 糖尿病診療支援システム
JP4533042B2 (ja) * 2004-08-25 2010-08-25 裕 笹川 糖尿病および糖代謝異常を判断する方法
WO2006036476A2 (en) * 2004-09-07 2006-04-06 The General Hospital Corporation Methods of detecting myocardial ischemia and myocardial infarction
JP4522222B2 (ja) * 2004-10-22 2010-08-11 扶桑薬品工業株式会社 血中脂肪酸濃度測定による心疾患の早期診断方法
WO2006063733A1 (en) * 2004-12-14 2006-06-22 F.Hoffmann-La Roche Ag Cd99 as target/marker for insulin resistance
WO2006066263A1 (en) 2004-12-17 2006-06-22 Entelos, Inc. Assessing insulin resistance using biomarkers
JPWO2006073195A1 (ja) * 2005-01-07 2008-06-12 敏一 吉川 糖尿病の予知・診断方法および糖尿病予知・診断用キット
FR2890079B1 (fr) * 2005-08-26 2007-11-30 Alain Rambach Detection des salmonelles lactose +
US20080280955A1 (en) * 2005-09-30 2008-11-13 Perlegen Sciences, Inc. Methods and compositions for screening and treatment of disorders of blood glucose regulation
EP1949105A4 (en) * 2005-10-11 2009-06-17 Tethys Bioscience Inc DIABETES ASSOCIATED MARKERS AND METHOD FOR USE THEREOF
JP2007127423A (ja) * 2005-10-31 2007-05-24 Toray Ind Inc 3−ヒドロキシ酪酸の測定方法およびキット
EP2339346B1 (en) * 2006-03-24 2014-09-03 Metanomics GmbH Methods for predicting diabetes type II
US8321154B2 (en) * 2007-03-26 2012-11-27 Bg Medicine, Inc. Methods for detecting coronary artery disease
MX2010000414A (es) * 2007-07-17 2010-04-01 Metabolon Inc Biomarcadores para prediabetes, enfermedades cardiovasculares y otros trastornos relacionados con sindrome metabolico, y metodos de uso de los mismos.
US20120122981A1 (en) * 2009-03-31 2012-05-17 Yun Fu Hu Biomarkers Related to Insulin Resistance and Methods using the Same
BR112013016071A2 (pt) * 2010-12-23 2016-09-20 Metanomics Health Gmbh "métodos, dispositivo e kit de diagnóstico de diabete e uso de glioxilato ou um agente de detecção para glioxilato"

Similar Documents

Publication Publication Date Title
JP2010537157A5 (https=)
JP2015064362A5 (https=)
Timar et al. The impact of diabetic neuropathy on balance and on the risk of falls in patients with type 2 diabetes mellitus: a cross-sectional study
Krolewski Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes
Ko et al. High prevalence of metabolic syndrome in Hong Kong Chinese—comparison of three diagnostic criteria
Janghorbani et al. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) as a screening tool for the metabolic syndrome
JP6404834B2 (ja) インスリン抵抗性の進行に関連するバイオマーカー及びこれを使用する方法
Sun et al. Metabolic syndrome and the development of chronic kidney disease among 118 924 non‐diabetic Taiwanese in a retrospective cohort
Viazzi et al. Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study
JP2012522989A5 (https=)
Lee et al. Comparing kidney outcomes in type 2 diabetes treated with different sulphonylureas in real-life clinical practice
Forti et al. Homocysteinemia and early outcome of acute ischemic stroke in elderly patients
Dasari et al. Glycemic variability is associated with markers of vascular stress in adolescents
Tangvoraphonkchai et al. Differences in prevalence of muscle weakness (sarcopenia) in haemodialysis patients determined by hand grip strength due to variation in guideline definitions of sarcopenia
Won et al. 1, 5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes
Ferlazzo et al. Saliva testing as noninvasive way for monitoring exercise-dependent response in teenage elite water polo players: A cohort study
Chan et al. Comprehensive malnutrition inflammation score as a marker of nutritional status in Chinese peritoneal dialysis patients
Mitrea et al. Wrist circumference: an independent predictor of both insulin resistance and chronic kidney disease in an elderly population
Ramteke et al. Evaluation of the efficacy and safety of bromocriptine QR in type 2 diabetes
Delaney et al. Pitfalls in the measurement of the nocturnal blood pressure dip in adolescents with type 1 diabetes
WO2016103390A1 (ja) インスリン分泌能分析装置、当該装置を備えるインスリン分泌能分析システム及びインスリン分泌能分析方法
CN118215844A (zh) 预测高血糖症可能性的方法
Sugimoto et al. Improved Detection of Decreased Glucose Handling Capacities via Novel Continuous Glucose Monitoring-Derived Indices: AC_Mean and AC_Var
Parial et al. Association of HbA1c, creatinine and lipid profile in patients with diabetic foot ulcer
Hou et al. The protective effect of Metformin/Donepezil in diabetic mice brain: evidence from bioinformatics analysis and experiments.